Can we risk transplantation across positive complement‐dependent cytotoxicity crossmatches in pediatric patients?

Should we continue to let complement-dependent cytotoxicity (CDC) crossmatches deny organs for sensitized patients? Or can we safely manage or prevent the potential complications associated with transplanting across a positive crossmatch? In the adult population, there are numerous studies showing poor clinical outcomes so that doing so, for the moment, is not standard of care. This article is protected by copyright. All rights reserved.

[1]  C. Canter,et al.  Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children‐04 (CTOTC‐04) in pediatric heart transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  C. Canter,et al.  Incidence, characterization, and impact of newly detected donor‐specific anti‐HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC‐04 study , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  C. Canter,et al.  Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC‐04 multi‐institutional study , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  Mary G. George,et al.  CDC Grand Rounds: Improving medication adherence for chronic disease management — Innovations and opportunities , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  D. Bernstein,et al.  Post-transplant outcomes in pediatric ventricular assist device patients: A PediMACS-Pediatric Heart Transplant Study linkage analysis. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  D. Mancini,et al.  Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  C. Canter,et al.  Pediatric Quality of Life while Supported with a Ventricular Assist Device. , 2015, Congenital heart disease.